Literature DB >> 25496313

Radioprotective effects of mitochondria-targeted antioxidant SkQR1.

Elena K Fetisova1, Margarita M Antoschina, Varvara D Cherepanynets, Denis S Izumov, Igor I Kireev, Roman I Kireev, Konstantin G Lyamzaev, Nikolay I Riabchenko, Boris V Chernyak, Vladimir P Skulachev.   

Abstract

We show here that mitochondria-targeted antioxidant composed of plastoquinone conjugated through hydrocarbon linker with cationic rhodamine 19 (SkQR1) protected against nuclear DNA damage induced by gamma radiation in K562 erythroleukemia cells. We also demonstrate that SkQR1 prevented the early (1 h postirradiation) accumulation of phosphorylated histone H2AX (γ-H2AX) an indicator of DNA double-strand break formation, as well as the radiation-induced increase in chromosomal aberrations. These data suggested that nuclear DNA damage induced by gamma radiation may be mediated by mitochondrial reactive oxygen species (ROS) production. We show that SkQR1 suppressed delayed accumulation of ROS 32 h after irradiation probably by inhibiting mitochondrial ROS-induced ROS release mechanisms. This suggests that mitochondria-targeted antioxidants may protect cells from the late consequences of radiation exposure related to delayed oxidative stress. We have previously reported that SkQRl is the substrate of multidrug resistance pump P-glycoproten (Pgp 170) and selectively protects Pgp 170-negative cells against oxidative stress. In line with this finding, we demonstrate here that SkQR1 did not protect Pgp170-positive K562 subline against DNA damage induced by gamma radiation. The selective radioprotection of normal Pgp 170-negative cells by mitochondria-targeted antioxidants could be a promising strategy to increase the efficiency of radiotherapy for multidrug-resistant tumors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25496313     DOI: 10.1667/RR13708.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  6 in total

Review 1.  Reduction-oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics.

Authors:  R Yahyapour; E Motevaseli; A Rezaeyan; H Abdollahi; B Farhood; M Cheki; S Rezapoor; D Shabeeb; A E Musa; M Najafi; V Villa
Journal:  Clin Transl Oncol       Date:  2018-01-09       Impact factor: 3.405

Review 2.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

3.  Late Administration of a Palladium Lipoic Acid Complex (POLY-MVA) Modifies Cardiac Mitochondria but Not Functional or Structural Manifestations of Radiation-Induced Heart Disease in a Rat Model.

Authors:  Vijayalakshmi Sridharan; John W Seawright; Francis J Antonawich; Merrill Garnett; Maohua Cao; Preeti Singh; Marjan Boerma
Journal:  Radiat Res       Date:  2017-02-23       Impact factor: 2.841

Review 4.  Addressing the Symptoms or Fixing the Problem? Developing Countermeasures against Normal Tissue Radiation Injury.

Authors:  Jacqueline P Williams; Laura Calvi; Joe V Chakkalakal; Jacob N Finkelstein; M Kerry O'Banion; Edward Puzas
Journal:  Radiat Res       Date:  2016-06-22       Impact factor: 2.841

Review 5.  Hematopoietic Stem Cells and Mesenchymal Stromal Cells in Acute Radiation Syndrome.

Authors:  Liren Qian; Jian Cen
Journal:  Oxid Med Cell Longev       Date:  2020-08-08       Impact factor: 6.543

6.  The Effect of High-Dose-Rate Pulsed Radiation on the Survival of Clinically Relevant Radioresistant Cells.

Authors:  Shingo Terashima; Hironori Yoshino; Yoshikazu Kuwahara; Hiro Sakuraba; Yoichiro Hosokawa
Journal:  Life (Basel)       Date:  2021-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.